European stock markets experienced a mixed to negative performance over the past week ending August 2, 2025, amid a barrage of corporate earnings, economic data releases, and ongoing global trade tensions.

The pan-European Stoxx 600 index closed the week lower, provisionally down about 1.2% on Friday after trading at a near one-month low, contributing to an overall weekly decline influenced by disappointing earnings and broader market pressures. Earlier in the week, it saw modest gains, up 0.33% on Tuesday and little changed on Wednesday.

Germany's DAX index fell sharply, losing 2.66% in a session to around 23,426 points by August 1, reflecting a monthly decline of 1.53%, though it remains significantly higher year-over-year.

The UK's FTSE 100 gained 0.60% on Tuesday but ended the week with subdued movements, impacted by data showing UK GDP contraction in June.

France's CAC 40 advanced 0.72% on Tuesday but slipped in later sessions, closing the week mixed amid earnings assessments and trade talk uncertainties.

Major market movers included Novo Nordisk, which plummeted 23% following disappointing Q2 results and a lowered 2025 outlook, dragging on the health care sector.

Significant earnings releases featured a wave of reports from European companies, with mixed results contributing to market volatility; for instance, Renk jumped on a stock upgrade in prior sessions, though overall sentiment was cautious.

Key economic events included UK GDP data indicating contraction in June, alongside regional growth figures andongoingU.S.-EU trade discussions that influenced investor sentiment.

Price movements across indices reflected broader risk-off sentiment, with global factors like U.S. macro data and trade tensions adding pressure.

Most searched or relevant tickers of the week highlighted investor focus on earnings-heavy names and major index components.